Thus, in IBD the S100B/microbiota interaction might even participate in pathogenic processes, such as chronic inflammation, which may involve TLR5 and/or TLR9, two recognised regulators of the mucosal immune response to microbiota [42]. The gene discussed is TLR9; the disease is inflammatory bowel disease.